There’s a push for free flu vaccines to be offered earlier, and for longer, as Perth hospitals brace for winter.
Jessica Page
Private hospital provider Ramsay Health Care says its after hours GP clinic in Joondalup will not be closing, just hours after media reported its future was under review.
Claire Sadler
Doctors are warning that complex elective surgery will be in limbo as the result of a decision to close two theatres at Sir Charles Gairdner Hospital ‘essentially permanently’, according to a leaked email.
The 88-year-old Perth grandmother is the latest face of a health system that’s buckling under growing pressure.
Research has revealed a worrying trend which could mean teenagers using meal prep plans are unknowingly missing essential calories — equivalent to skipping a meal.
Families affected by the condition and a dedicated support crew walked 92km across Perth over four days to raise funds and awareness for Duchenne muscular dystrophy.
Caitlin Vinci
Discount pharmacy juggernaut Chemist Warehouse has attributed its double-digit sales lift to the growing popularity of weight-loss drugs like Ozempic and Mounjaro.
Cheyanne Enciso
Private health funds are trying to lure new customers with gift cards, zero wait periods and free insurance for up to 14 weeks.
Rhianna Mitchell
Health insurer Medibank Private has lifted its interim bottom-line net profit after the number of Australians taking out policies increased.
Kaaren Morrissey
Shares in Medibank and Nib have jumped after both insurers announced premium hikes of more than 5 per cent for 2026.
Federal Health Minister Mark Butler says premiums will increase by an average 4.41 per cent from April, up from the previous year’s 3.73 per cent rise.
Sean Smith and Caitlyn Rintoul
In the internet age, consent is bypassed in a world where privacy is hard to find says Professor Gary Martin.
Gary Martin
Hearing device manufacturer Cochlear has posted weaker-than-expected half-year earnings and trimmed its guidance, leading to a double-digit sell-off.
Staff Writers
OncoRes has secured nearly $30 million in funding in what the medical technology firm — which wants to crack the huge US market — says will help progress clinical trials for its breast cancer detecting probe.
Biopharmaceutical group CSL isn't happy with its performance after reporting a big fall in interim earnings, a day after its chief executive's shock retirement.
A damning report into the $50 billion National Disability Insurance Scheme has sounded the alarm on dodgy tactics by providers, including bogus claims of taxpayer-funded overseas holidays.
HBF Ventures will be managed by alternative investment firm Artesian and invest in up to 20 early and growth stage companies over 10 years.
Sean Smith
The appointments of Isar Mazer and Russell Baskerville as non-executive directors lift board numbers back out to nine ahead of the proposed retirement of deputy chair Brent Stewart later this year..
Construction tenders for upgrading hospitals in both the Great Southern and Mid West have been awarded to a single contractor.
Amy Towers
Healthscope’s lenders have backed a proposal to turn the nation’s second-biggest hospital operator into a not-for-profit company following last year’s spectacular financial collapse.
January has brought a reprieve after a record flu season for WA last year but as school returns experts are urging families to get protected against the infectious disease.
While weight-loss drugmaker Novo is bracing for a sales decline, rival Lilly sees revenue charging ahead thanks to its blockbuster medicines.
Annika Kim Constantino
As the Great Southern’s population continues to grow and pressure on the public health system mounts, a specialist clinic has emerged to save oft-forgotten regional patients from falling through the cracks.
Melissa Sheil
PYC Therapeutics boss Rohan Hockings is hoping to strike while the iron is hot with a monster $600 million equity raising to advance a pipeline of drugs aimed at treating rare genetic diseases out to 2030.
